Advertisement

Topics

Petra Pharma Names Brian O’Callaghan CEO and Fills CSO, CFO Posts

19:01 EDT 28 Jul 2017 | Xconomy

Brian O’Callaghan has been appointed CEO of Petra Pharma, a New York biotech developing drugs to treat cancer and metabolic diseases. O’Callaghan’s experience includes senior positions at Pfizer (NYSE: PFE), Novartis (NYSE: NVS), Merck Serono, NPS, and Covance. Petra also named David McElligott chief scientific officer, and David Renas chief financial officer. The company, which […]

Original Article: Petra Pharma Names Brian O’Callaghan CEO and Fills CSO, CFO Posts

NEXT ARTICLE

More From BioPortfolio on "Petra Pharma Names Brian O’Callaghan CEO and Fills CSO, CFO Posts"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...